Incidence and mortality of primary liver cancer in England and Wales: Changing patterns and ethnic variations

Figure 1 Age-standardised (A) mortality and (B) incidence rates of primary liver cancer, hepatocellular carcinoma, intrahepatic bile duct carcinoma and unspecified liver tumours (liver tumours, not otherwise specified) by gender and year. PLC: Primary liver cancer; HCC: Hepatocellular carcinoma; IHBD: Intrahepatic bile duct carcinoma; NOS: Not otherwise specified.

Figure 2 Proportion (%) of registrations (incidence) of primary liver cancer, hepatocellular carcinoma, intrahepatic bile duct carcinoma and liver tumours, not otherwise specified by the basis of diagnosis, England and Wales, 1993-2008. PLC: Primary liver cancer; HCC: Hepatocellular carcinoma; IHBD: Intrahepatic bile duct carcinoma; NOS: Not otherwise specified.

Figure 3 Comparison of ethnic groups in England and Wales (2008), as recorded in the (A) population of England and Wales, and the registration of (B) hepatocellular carcinoma, (C) intrahepatic bile duct carcinoma, and (D) liver tumours, not otherwise specified.

Figure 4 Estimated relative survival (A) 5 yr and (B) 10 yr projections; obtained from complement of mortality to incidence ratios × 100 that was extrapolated from 2008 to 2018. PLC: Primary liver cancer; HCC: Hepatocellular carcinoma; IHBD: Intrahepatic bile duct carcinoma.